China Pharmaceutical (CFMI) 0.0051 $CFMI SciClone

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Pharmaceutical (CFMI) 0.0051 $CFMI

SciClone Reports Third Quarter 2015 Financial Results
PR Newswire - Mon Nov 09, 3:05PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended September 30, 2015.
SCLN: 10.33 (-0.37)

Global Pharmaceuticals RFID Industry Forecast Report, Market Outlook 2014
M2 - Tue Oct 27, 4:38AM CDT
Product Synopsis

Market Analysis Of Global Pharmaceutical Industries And Trend Estimation Featuring Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline & Eli Lilly & Company
M2 - Mon Aug 17, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/22ql9d/market_analysis) has announced the addition of the "Market Analysis Of Global Pharmaceutical Industries And Trend Estimation" report to their offering. The report analyzes the global trend of pharmaceutical industries. It gives vivid profile of generic drugs and emerging market across the globe. A comprehensive market analysis of Germany, Russia, US, Australia, China and India has been presented. Analysis covers market capacity, market value, drug consumption, healthcare expenditure, export and import of drugs, retail commercial market, hospital sale, key achievements and developments, markets around different kinds of drugs etc. The report presents financial analysis of top pharmaceutical companies like Pfizer, Johnson and Johnson, Abbott, Gilead, Sun Pharma, Glaxo Smith Kline, Eli Lilly & Company. The latest annual reports of all companies were analyzed and compared with earlier reports so as to decipher market trends. Key issues involved in pharmaceutical supply chain for optimization have been identified. Management, discussion and analysis reports of global pharmaceutical industries are an added feature of this report. The future global market trend for coming years has been predicted in light of enormous data collected from various sources. Key Topics Covered: 1. Pharmaceutical And Pharmaceutical Company 1.1 Pharmaceutical Company 1.2 Definition Of Medicinal Product Or Drug 1.3 Classification Of Drugs 1.4 History Of Drugs 1.5 Ancient Pharmacology 1.6 Medieval Pharmacology 1.7 Modern Pharmacology 1.8 Drugs And Intellectual Property Rights 2. Generic Industry 2.1 Generic Industry 2.2 Introduction To The Generic Market 2.3 Leading Companies In The Generic Industry 2.4 The Generic Industry And Mergers & Acquisitions 2.5 Generic Industry & Emerging Markets 2.6 Conclusion To The Generics Industry 3. Pharmaceutical Industries In Selected Countries Of The World 3.1 German Pharmaceutical Industry 3.2 Russian Pharmaceutical Market 3.3 Russian Pharma Company 3.4 Russian Pharmaceuticals Market 3.5 Us Pharmaceuticals Market 3.6 Australia Pharmaceuticals Industry 3.7 China Pharmaceuticals Industry 3.8 Indian Pharmaceuticals Industry 4. Financial Analysis Of Top Pharmaceutical Companies 4.1 Pfizer 4.2 Johnson & Johnson 4.3 Abbott Pharmaceuticals 4.4 Gilead 4.5 Sun Pharma 4.6 Glaxo Smith Kline Annual Report 4.7 Eli Lilly & Company Annual Report 5. Pharmaceutical Supply Chains: Key Issues And Strategies For Optimisation 5.1 Trends In The Pharmaceutical And Related Industries 5.2 Value Chains 5.3 Supply Chains 5.4 Process, Development & Design 5.5 Optimised Planning Of Tests 5.6 Capacity And Portfolio Planning Under Uncertainty 5.7 Combined Testing And Capacity Planning 5.8 Classical Supply Chain Planning And Management 5.9 Issues/Structure 5.10 Dynamic Supply Chain Analysis 5.11 A Particular Market 5.12 Comparison Of Two Supply Chain Responses 5.13 Some Conclusions 5.14 Future Perspectives 6. Management, Discussion And Analysis Report Of Global Pharma Industry 7. Summary For more information visit http://www.researchandmarkets.com/research/22...t_analysis
LLY: 82.42 (-0.30)

Pharmaceutical Directory of China 2015
M2 - Tue Jul 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wz73cd/pharmaceutical) has announced the addition of the "Pharmaceutical Directory of China 2015" directory to their offering. The Chinese pharmaceutical industry has increased with high annual average growth rates over the last few decades. And during 2014 this strong growth is expected to continue unabated. This new edition of the China Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to China's ever-changing pharmaceutical industry. If you need to source from, or sell to China, Pharmaceuticals, Biopharmaceuticals, Bulk Pharmaceuticals, OTC/Healthcare products, Research & Development, Fine Chemicals, Generics, Genomics, or Diagnostics/Reagents; or, if you're looking to break into this appealing market, the new China Pharmaceutical Directory will provide you with thousands of fresh business contacts - and help you keep track of old ones - quickly and easily. This one directory covers the entire Chinese pharmaceutical & biotechnology industries sector. This Directory will enable you to: - Profile a market - Build new business prospects - Pinpoint key executives - Generate new customers - Discover who your competitors are - Make vital contacts - Save the time, money and effort of doing your own research - Identify alternative suppliers and manufacturers - Source up-to-date company information - Access a wealth of quality information on companies and key personnel. Look at the information you'll get in the China Pharmaceutical Directory: - Address - Telephone, fax numbers - Email, website - Names of senior management and board members - Senior executives - Description of business activities - Subsidiaries and associates - Number of employees For more information visit http://www.researchandmarkets.com/research/wz...maceutical

China Pharmaceuticals Markets Research And Forecast Report: Radiant Insights
M2 - Wed Jun 03, 11:42AM CDT
RadiantInsights.com has announced the addition of "China Pharmaceuticals Markets Trends, Growth And Forecast Report : Radiant Insights, Inc" Market Research Report to their Database.

China Pharmaceuticals Markets Growth, Trends
M2 - Tue Jun 02, 7:47AM CDT
China's demand for Pharmaceuticals (http://www.radiantinsights.com/research/pharmaceuticals-markets-in-china) has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.

China Pharmaceuticals and Healthcare Report Q1 2015
PR Newswire - Wed Dec 24, 7:30AM CST
BMI View:Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 514

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 391

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Kinross Gold: A Decade of Growth Analysis

Updated Category News Views 173

Investing in Kinross Gold: A Decade of Growth Kinross Gold (NYSE: KGC), an influential player in the mining industry, has showcased a remarkable performance over the past decade. With an impressive annualized return of 28.15% that exceeds market benchmarks by 15.29%, investors have much to consider regarding the potential of this gold mining giant. The Impact of...

Continue Reading
Chagee Holdings Limited Reports Robust Financial Growth in Q2 2025

Updated Category News Views 391

Chagee Holdings Limited Shows Impressive Growth in Q2 2025 Chagee Holdings Limited (NASDAQ: CHA), a prominent player in the premium tea drinks sector, has reported impressive unaudited financial results for the second quarter of the financial year. The company, renowned for its innovative approach to freshly-made tea drinks, has made significant strides as it continues to...

Continue Reading
Recent Notification on Major Holdings of RENEWI PLC

Updated Category News Views 149

Understanding Major Holdings in RENEWI PLC Investors and stakeholders often seek clarity on significant holdings within companies. This not only shapes perceptions but also influences future decisions and strategies. RENEWI PLC has recently documented changes regarding its holdings and the requirements for notifying stakeholders. This disclosure is crucial for those...

Continue Reading
Gold Port Corporation Expands Private Placement Funding

Updated Category News Views 244

Gold Port Corporation Increases Private Placement to Meet Demand Gold Port Corporation (CSE: GPO) is excited to announce an increase in its non-brokered private placement as a response to significant investor interest. Originally set to raise $1,500,000 through the sale of 20,000,000 units at a price of $0.075 per unit, the company is now keen on maximizing this...

Continue Reading
Ensemble Enhances Patient Care with Strategic Partnership

Updated Category News Views 83

Ensemble made headlines by teaming up with Mary Washington Healthcare (MWHC) in a move that was supposed to revolutionize healthcare services. Back then, the talk was all about boosting financial performance and enhancing patient experiences through some fancy technology. Traders kept an eye on this partnership, pondering whether it could be more than just corporate...

Continue Reading